Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer
- PMID: 30733298
- PMCID: PMC6397588
- DOI: 10.1073/pnas.1817652116
Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer
Abstract
Infiltration of [Formula: see text] T lymphocytes into solid tumors is associated with good prognosis in various types of cancer, including triple-negative breast cancer (TNBC). However, the mechanisms underlying different infiltration levels are largely unknown. Here, we have characterized the spatial profile of [Formula: see text] T cells around tumor cell clusters (tightly connected tumor cells) in the core and margin regions in TNBC patient samples. We found that in some patients, the [Formula: see text] T cell density first decreases when moving in from the boundary of the tumor cell clusters and then rises again when approaching the center. To explain various infiltration profiles, we modeled the dynamics of T cell density via partial differential equations. We spatially modulated the diffusion/chemotactic coefficients of T cells (to mimic physical barriers) or introduced the localized secretion of a diffusing T cell chemorepellent. Combining the spatial-profile analysis and the modeling led to support for the second idea; i.e., there exists a possible chemorepellent inside tumor cell clusters, which prevents [Formula: see text] T cells from infiltrating into tumor cell clusters. This conclusion was consistent with an investigation into the properties of collagen fibers which suggested that variations in desmoplastic elements does not limit infiltration of [Formula: see text] T lymphocytes, as we did not observe significant correlations between the level of T cell infiltration and fiber properties. Our work provides evidence that [Formula: see text] T cells can cross typical fibrotic barriers and thus their infiltration into tumor clusters is governed by other mechanisms possibly involving a local repellent.
Keywords: ECM; TIL; TNBC; chemokine; tumor-cell clusters.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.Hum Pathol. 2017 Nov;69:110-117. doi: 10.1016/j.humpath.2017.09.012. Epub 2017 Oct 6. Hum Pathol. 2017. PMID: 28993275
-
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.Breast Cancer Res Treat. 2016 Apr;156(2):237-47. doi: 10.1007/s10549-016-3743-x. Epub 2016 Mar 9. Breast Cancer Res Treat. 2016. PMID: 26960711
-
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.Breast Cancer Res. 2015 Sep 4;17(1):124. doi: 10.1186/s13058-015-0632-x. Breast Cancer Res. 2015. PMID: 26341640 Free PMC article.
-
Role of inflammatory infiltrates in triple negative breast cancer.J Clin Pathol. 2015 Jul;68(7):506-10. doi: 10.1136/jclinpath-2015-202944. Epub 2015 Mar 6. J Clin Pathol. 2015. PMID: 25750267 Review.
-
The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.Breast Cancer Res Treat. 2014 Dec;148(3):467-76. doi: 10.1007/s10549-014-3185-2. Epub 2014 Nov 1. Breast Cancer Res Treat. 2014. PMID: 25361613 Review.
Cited by
-
Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS/STING in non-small cell lung cancer.Cell Death Discov. 2022 Nov 28;8(1):468. doi: 10.1038/s41420-022-01256-2. Cell Death Discov. 2022. PMID: 36443299 Free PMC article.
-
Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response.Cancers (Basel). 2022 May 20;14(10):2525. doi: 10.3390/cancers14102525. Cancers (Basel). 2022. PMID: 35626126 Free PMC article.
-
Quantitative evaluation of tumor-specific T cells in tumors and lymphoid tissues.Methods Enzymol. 2020;635:149-166. doi: 10.1016/bs.mie.2019.05.041. Epub 2019 Jun 25. Methods Enzymol. 2020. PMID: 32122543 Free PMC article.
-
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.Cancer Discov. 2024 Jun 3;14(6):1018-1047. doi: 10.1158/2159-8290.CD-23-1380. Cancer Discov. 2024. PMID: 38581685 Free PMC article.
-
Stromal Protein-Mediated Immune Regulation in Digestive Cancers.Cancers (Basel). 2021 Jan 5;13(1):146. doi: 10.3390/cancers13010146. Cancers (Basel). 2021. PMID: 33466303 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
